Magnolia Medical Technologies is an early-stage institutional investor-backed commercial medical device company that develops, manufactures and markets innovative blood and bodily fluid collection devices that significantly improve the accuracy, consistency and predictability of critical laboratory tests. False positive and false negative test results in the acute care setting commonly create confusion and uncertainty that routinely lead to inappropriate, unnecessary treatments.

Misdiagnoses due to inaccurate test results often significantly increase utilization of powerful antibiotics which are associated with complications and extended patient length of stay as well as risk for hospital-acquired-infections andconditions (HAIs and HACs). Through innovative device design, Magnolia’s products mechanically eliminate human errors that cause preventable inaccurate test results, significantly improving patient safety, care and experience as well as driving Antimicrobial Stewardship, CMS quality outcome metrics, and reducing overall hospital costs.

The company’s flagship product, Steripath® Blood Culture Collection and Contamination Prevention System, is the only technology clinically proven to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of Sepsis – delivering sustained contamination rates as low as 0.2% with an average reduction in false positives of 92%.

Results from a recent clinical trial conducted by Dr. Mark Rupp, Chief of Infectious Diseases at University of Nebraska Medical Center, were published in Clinical Infectious Diseases, July 2017. Steripath demonstrated a 0.2% blood culturecontamination rate sustained for an entire year, representing a 92% reduction compared to the pre-trial contamination rate of 2.6% with an estimated annual savings of $1.8 million dollars for their facility.

Magnolia is establishing a new standard-of-care for blood culture integrity and sepsis testing accuracy. Dr. Richard Patton, the company’s co-founder and Medical Director, invented and patented the Initial Specimen Diversion Technique (ISDT™) and Initial Specimen Diversion Device (ISDD®) for blood culture collection, and wrote the seminal peer-reviewed publication on this technique published in the Journal of Clinical Microbiology in 2010.

Magnolia has amassed an extensive IP portfolio protecting its products including 60 issued method, apparatus and design patents encompassing nearly 600 claims. The company also has more than 50 additional pending patent applications filed to date. The total potential market for Magnolia’s technology exceeds $2.0 billion annually.

PURPOSE OF THE JOB

This is a clinical specialist position responsible for leading clinical evaluations, implementations and compliance programs to achieve and ensure sustained outcomes. It is a field-based position. Complete ability to clearly, accurately and passionately articulate the clinical and economic value proposition of Magnolia’s product portfolio to prospective and current customers is a must.

Primary interaction is with hospital administration, emergency department and critical care nurses and directors, microbiology lab managers and directors, phlebotomy managers, infection preventionists, infectious disease physicians and supply chain managers. Qualified candidates should be an RN with a minimum of 3-4 years combined experience in a clinical acute care setting, and clinical education and training within the hospital setting or a hospital-based medical device company.

MAJOR DUTIES AND RESPONSIBILITIES

• Ensure successful clinical implementation, evaluation and long-term use of the Steripath product portfolio, driving high user compliance and customer
• Provides training and education to hospital administration and end-users on blood culture collection and Steripath best practices and the collection, tracking and reporting of key blood culture and contamination
• Monthly tracking and reporting of each account’s blood culture and contamination metrics.
• Collaborate with field sales in team clinical selling to close new business and expand current
• Efficiently collaborates in the development and execution of plans to achieve optimal growth and optimal business /clinical partnerships in
• Provides strategic recommendations to address customer needs and business
• Proficiently leverages use of other supporting staff to optimize account retention and sales
• Prioritizes accounts to determine coverage, assesses opportunity and develop new business.
• Establish effective processes for internal cross functional and external
• Collaborates and communicates routinely with the Director of Clinical Operations, clinical team and sales
• Maintains strong industry, product and clinical knowledge
• Proactively develops and maintains broad knowledge of blood culture process as well as hospital, patient and economic
• Manages time and resources effectively to meet company objectives
• Establishes and maintains highly effective relationships with clinical team, sales team, executive team andclients
• Proactively identifies the potential needs of the client to ensure customer engagement and sustained
• Clearly articulates product value to clinical customers with detailed description
• Interacts directly with hospital administration as well as staff initiating discussions to obtain in-depth customer feedback for Steripath opportunities
• Identifies business needs of prospective customers and collaborates with Clinical Managers and Clinical Director to present solutions based on client’s needs
• Creates a relationship of interdependency with customer so the cost of change is prohibitive to bothparties

PREFERRED QUALIFICATIONS

• RN associate degree required; BSN
• Must have minimum of 2 years of experience in an acute or critical care clinical setting, and 1-2 years of experience in clinical education and training (unit educator, preceptor, charge nurse)
• Experience in the emergency department, intensive and critical care, vascular access, infection prevention or infectious diseases
• Knowledge and understanding of blood culture collection technique and procedures is preferred.
• Possesses effective and inspirational speaking skills as an expert in contaminated blood cultures
• Demonstrates extensive knowledge and understanding of relevant hospital systems and needs.

SPECIAL SKILLS, ABILITIES AND REQUIREMENTS

• Must be adept at communicating clinical subjects to stakeholders and non-clinical subjects
• Broad clinical and business knowledge as well as specialized knowledge in IV therapy, infection prevention or related field
• Minimum of 3 years in acute care nursing
• Minimum of 2 years in medical device industry as a clinical educator
• Must be a problem solver with the ability to think on their feet
• Ability to manage responsibilities with competing demands for time
• Expert collaborative and interpersonal skills
• Outstanding verbal, written and presentation skills
• Must have demonstrated project, team and time management capability
• Travel 75% plus

Magnolia is committed to the continued development and successful marketing of innovative products that will transform the way healthcare is practiced around the world. The company will support this effort by offering competitive compensation, incentive packages, benefits and career growth opportunities to the most qualified candidates in the marketplace to build a world-class organization. Magnolia Medical Technologies, Inc. is an equal opportunity employer and value diversity at our company.

For more information, visit magnolia-medical.com

**As a condition of employment with Magnolia Medical Technologies, you are required to provide proof that you are fully vaccinated against COVID-19 or qualify for a reasonable accommodation.